CN101121922A - 酿酒酵母细胞培养分泌液制备方法及其抗dna病毒和促肝细胞生长的用途 - Google Patents
酿酒酵母细胞培养分泌液制备方法及其抗dna病毒和促肝细胞生长的用途 Download PDFInfo
- Publication number
- CN101121922A CN101121922A CN 200610089194 CN200610089194A CN101121922A CN 101121922 A CN101121922 A CN 101121922A CN 200610089194 CN200610089194 CN 200610089194 CN 200610089194 A CN200610089194 A CN 200610089194A CN 101121922 A CN101121922 A CN 101121922A
- Authority
- CN
- China
- Prior art keywords
- yeast cell
- juice
- brewing yeast
- nutrient solution
- cultivated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 15
- 210000005253 yeast cell Anatomy 0.000 title claims description 42
- 238000002360 preparation method Methods 0.000 title claims description 14
- 210000003494 hepatocyte Anatomy 0.000 title abstract description 13
- 238000004113 cell culture Methods 0.000 title abstract description 6
- 230000028327 secretion Effects 0.000 title abstract description 6
- 230000001737 promoting effect Effects 0.000 title 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 37
- 235000015097 nutrients Nutrition 0.000 claims description 32
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 241000700721 Hepatitis B virus Species 0.000 claims description 9
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 239000000413 hydrolysate Substances 0.000 claims description 9
- 241000894006 Bacteria Species 0.000 claims description 5
- 208000006454 hepatitis Diseases 0.000 claims description 5
- 238000005374 membrane filtration Methods 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 4
- 231100000283 hepatitis Toxicity 0.000 claims description 4
- 230000000813 microbial effect Effects 0.000 claims description 4
- 206010019837 Hepatocellular injury Diseases 0.000 claims description 2
- 241001631646 Papillomaviridae Species 0.000 claims description 2
- 241000700584 Simplexvirus Species 0.000 claims description 2
- 231100000437 hepatocellular injury Toxicity 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 abstract description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract description 5
- 206010067125 Liver injury Diseases 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract description 2
- 231100000753 hepatic injury Toxicity 0.000 abstract description 2
- 208000002672 hepatitis B Diseases 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 230000001133 acceleration Effects 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 22
- 101710142246 External core antigen Proteins 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 210000005229 liver cell Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 241000204031 Mycoplasma Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 102000002734 Collagen Type VI Human genes 0.000 description 2
- 108010043741 Collagen Type VI Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000007541 cellular toxicity Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000009795 fibrotic process Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 210000000208 hepatic perisinusoidal cell Anatomy 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
培养上清液P/N值 | ||
培养时间(天) | HBsAg | HBeAg |
3 | 3.82 | 5.41 |
6 | 7.45 | 9.56 |
9 | 16.10 | 21.31 |
12 | 16.83 | 21.85 |
15 | 16.32 | 21.79 |
18 | 15.37 | 20.92 |
21 | 12.62 | 18.61 |
24 | 9.32 | 16.14 |
HBsAg | 酿酒酵母细胞培养液稀释度(1:) | |||||
100 | 200 | 500 | 1000 | 2000 | 4000 | |
96.62 | 88.52 | 75.83 | 52.11 | 37.81 | 26.27 | |
HBeAg | 99.17 | 93.22 | 87.54 | 75.13 | 59.85 | 48.13 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100891942A CN101121922B (zh) | 2006-08-08 | 2006-08-08 | 酿酒酵母细胞培养分泌液制备方法及其抗dna病毒和促肝细胞生长的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100891942A CN101121922B (zh) | 2006-08-08 | 2006-08-08 | 酿酒酵母细胞培养分泌液制备方法及其抗dna病毒和促肝细胞生长的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101121922A true CN101121922A (zh) | 2008-02-13 |
CN101121922B CN101121922B (zh) | 2010-11-10 |
Family
ID=39084421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100891942A Expired - Fee Related CN101121922B (zh) | 2006-08-08 | 2006-08-08 | 酿酒酵母细胞培养分泌液制备方法及其抗dna病毒和促肝细胞生长的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101121922B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102812119A (zh) * | 2010-03-26 | 2012-12-05 | 朝日集团控股株式会社 | 酵母培养方法 |
CN109517748A (zh) * | 2018-11-30 | 2019-03-26 | 吉林大学 | 黑色食物小分子肽在修复肝损伤中的医用用途 |
-
2006
- 2006-08-08 CN CN2006100891942A patent/CN101121922B/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102812119A (zh) * | 2010-03-26 | 2012-12-05 | 朝日集团控股株式会社 | 酵母培养方法 |
CN102812119B (zh) * | 2010-03-26 | 2015-05-20 | 朝日集团控股株式会社 | 酵母培养方法 |
CN109517748A (zh) * | 2018-11-30 | 2019-03-26 | 吉林大学 | 黑色食物小分子肽在修复肝损伤中的医用用途 |
Also Published As
Publication number | Publication date |
---|---|
CN101121922B (zh) | 2010-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103416223B (zh) | 一种提高北冬虫夏草发酵液中虫草素产量的方法 | |
CN102559828B (zh) | 一种通过微生物转化黄芪总皂苷制备黄芪甲苷的方法 | |
CN110305798A (zh) | 一株曲霉菌的用途及由该曲霉菌制备的化合物及其用途 | |
CN111803533A (zh) | 降血糖、降血脂组合物、制备方法及其应用 | |
CN113564212A (zh) | 一种利用微生物发酵法提取杜仲叶多糖的方法 | |
CN106047713A (zh) | 一株嗜松篮状菌菌株Li‑93及其应用 | |
CN102220281A (zh) | 一种肝细胞与Kupffer细胞共培养体系及其应用 | |
CN101121922B (zh) | 酿酒酵母细胞培养分泌液制备方法及其抗dna病毒和促肝细胞生长的用途 | |
CN109588319A (zh) | 一种利用固定化黄芪细胞生产黄芪活性成分的方法 | |
CN103740614B (zh) | 一株高产雷帕霉素的游动放线菌诱变菌株 | |
CN102363796A (zh) | 一种微生物发酵转化生产甘草次酸的方法 | |
CN103283482B (zh) | 蛹虫草、培养方法和分离方法 | |
CN103782794A (zh) | 一种促进冬虫夏草菌产分生孢子的方法 | |
CN101914452B (zh) | 石杉碱甲高产菌株tcm-01 | |
CN101407767A (zh) | 一种通过发酵生产冬虫夏草的方法 | |
CN104278070A (zh) | 一种提高桑黄液体发酵产物中麦角甾醇含量的方法 | |
CN1986775A (zh) | 适用于淡豆豉纯种发酵的枯草芽孢杆菌菌株 | |
CN104404103B (zh) | 一种提高马齿苋多糖的方法及该方法制备的发酵液 | |
CN103222479B (zh) | 盐屋链霉菌代谢产物在防治菜豆炭疽病菌中的应用 | |
CN113773985A (zh) | 提高中药多糖得率并调节皮肤屏障及免疫的枯草芽孢杆菌 | |
CN108977368A (zh) | 一种生产虫草菌粉的固体培养基及生产虫草菌粉的方法 | |
CN100510054C (zh) | 一种真菌提取物的制备及在抗人类免疫缺陷病毒中的应用 | |
CN105624075B (zh) | 一种肋生盐弧菌 | |
CN105112296B (zh) | 一株角担菌菌株及其在制备缬草素、镇静安眠类中成药中的应用 | |
CN113181222B (zh) | 一株隐球酵母的胞外多糖代谢产物在制备抗病毒药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Mao Panyong Inventor after: Bai Bingke Inventor after: Liu Hong Inventor after: Hu Yan Inventor after: Xin Shaojie Inventor after: Li Jin Inventor after: Gao Rong Inventor after: Shen Honghui Inventor after: Wang Zhijie Inventor after: Hou Jun Inventor before: Mao Panyong Inventor before: Liu Hong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: MAO PANYONG LIU HONG TO: MAO PANYONG LIU HONG HU YAN XIN SHAOJIE LI JIN GAO RONG SHEN HONGHUI WANG ZHIJIE HOU JUN BAI BINGKE |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101110 Termination date: 20210808 |
|
CF01 | Termination of patent right due to non-payment of annual fee |